Cutting-Edge Breast Cancer Screening Technology Available to Patients at UPMC Kane
UPMC Kane brings breakthrough breast cancer imaging to the community by now offering patients three-dimensional mammography imaging technology known as tomosynthesis.
Tomosynthesis uses precise, 3-D digital imaging to create a complete reconstruction of the breast, which gives radiologists the ability to identify certain abnormalities which can be more difficult to detect with traditional 2-D digital mammography screening.
“Tomosynthesis gives us the ability to improve upon the limitations of traditional mammography, hopefully allowing us to find more cancers with fewer false-positives,” said Jamil Sarfraz, M.D., director of diagnostic imaging services at UPMC Kane. “We are excited to provide this technology to our patients.”
Much of the initial tomosynthesis research was conducted at Magee-Womens Hospital of UPMC in Pittsburgh, and Magee researchers are the most widely published group in the U.S. on the technology. Magee researchers played a pivotal role in developing this technology.
Magee research has shown tomosynthesis screening significantly reduces false-positive diagnoses, limiting the number of additional workups and potentially unnecessary biopsies. Tomosynthesis may also be able to detect certain types of cancer lesions that are harder to detect on traditional mammography, particularly for women with dense breast tissue.
Screenings can be scheduled at the imaging center or by calling 814-837-4580, or toll-free at 800-565-9200 ext. 4580.